Clinical Trials Browser

Phase 2 × Lymphoma, T-Cell, Cutaneous × Doxorubicin × Clear all

NCT05996185 2026-04-14

Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma

Phase 2 Recruiting

DermatologicLymphoidOther hematologic neoplasm

Recurrence, Lymphoma, T-Cell, Lymphoma, T-Cell, Cutaneous, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT00002557 2013-12-18

Combination Chemotherapy in Patients With Advanced or Recurrent Mycosis Fungoides

Phase 2 Unknown

DermatologicLymphoid

Lymphoma, Lymphoma, T-Cell, Cutaneous